PRESSR: King Faisal Specialist Hospital & Research Centre wins 2024 Tech Impact Award from VBHC

First published: 17-May-2024 11:33:24

RIYADH, Saudi Arabia: (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSHRC) has achieved a significant milestone by winning the 2024 Tech Impact Award, a prestigious recognition presented by the Value-Based Health Care Centre Europe. This accolade, awarded for its pioneering Home Hemodialysis (HHD) initiative, underscores KFSHRC's unwavering commitment to comprehensive healthcare and further cement its position as a global leader in the healthcare industry.

The award-winning initiative is a testament to KFSHRC's patient-centric approach, designed to address the unique needs of kidney patients with advanced medical conditions, physical disabilities, and mobility challenges. This comprehensive system of continuous and supportive care, delivered in the comfort of their homes, not only ensures the highest standards of safety and comfort but also significantly improves their quality of life.

Dr. Wael Habhab, Chairman of the Internal Medicine Department at KFSHRC in Jeddah and a leading physician for the Home Hemodialysis initiative, stated, "The initial outcomes of the initiative revealed a substantial reduction in emergency room visits and hospital admissions, as well as lower re-hospitalization rates." He also confirmed that the initiative has greatly alleviated the burden of managing medications for bone and mineral diseases associated with chronic kidney failure, alongside a decreased need for intravenous medication injections.

The award is granted to healthcare institutions that offer innovative solutions, contribute to tangible outcomes, reduce costs, and enhance patient value, all within a framework of genuine engagement between healthcare providers and patients, redefining healthcare standards to provide exceptional, patient-centered services.

It is noteworthy that KFSHRC stands among the global leaders in providing specialized healthcare, driving innovation, and serving as an advanced medical research and education hub. Through strategic partnerships with prominent local, regional, and international institutions, the hospital is dedicated to advancing medical technologies and elevating the standards of healthcare worldwide.

King Faisal Specialist Hospital & Research Centre has been ranked first in the Kingdom and 20th globally, in the list of the world’s top 250 healthcare institutions for the second consecutive year and recognized as the most-valuable healthcare brand in the Kingdom and the Middle East, according to 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best hospitals by the prestigious Newsweek magazine.

For further information, please contact:

Mr. Essam AlZahrani, Acting Head of Media Affairs, 0555254429

Mr. Abdullah Alown, Media Coordination Officer, 0556294232

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.